Bionano Genomics Presents at H.C. Wainwright Investor Conference

What Happened
Bionano Genomics, Inc. (BNGO) filed a Form 8-K on September 14, 2026 (Item 7.01) disclosing that Al Luderer, Ph.D., the Company’s Chairman and Interim Chief Executive Officer, presented at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation to be used at the conference was furnished with the filing as Exhibit 99.1. The report was signed by Albert A. Luderer, Ph.D., on September 14, 2026.

Key Details

• Date of filing/presentation disclosure: September 14, 2026.
• Presenter: Al (Albert A.) Luderer, Ph.D., Chairman and Interim CEO.
• Event: H.C. Wainwright 28th Annual Global Investment Conference.
• Exhibit: Presentation furnished with the 8-K as Exhibit 99.1.

Why It Matters
This is a Regulation FD disclosure, meaning the company publicly furnished the presentation materials used by its interim CEO so all investors have the same access to the information presented. Investors who want details on any business, strategic, or operational commentary made at the conference should review Exhibit 99.1 in the 8-K.